Beranda › Limfoma Zona Marginal › Utah › Salt Lake City
Uji klinis Limfoma Zona Marginal di Salt Lake City, UT
6 studi untuk Limfoma Zona Marginal mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- Intermountain Healthcare, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Menerima pesertaFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
Menerima pesertaFase 2
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Menerima pesertaFase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Salt Lake City
Uji klinis Limfoma Zona Marginal di kota lain
- Durham, NC12 studi
- New York City, NY11 studi
- Seattle, WA9 studi
- Boston, MA9 studi
- Milwaukee, WI9 studi
- Baldwin Park, CA9 studi
- Houston, TX8 studi
- Rochester, MN8 studi
- Columbus, OH8 studi
- Edison, NJ8 studi
- Nashville, TN7 studi
- Miami, FL7 studi
Studi lain di Salt Lake City
- Kanker Paru Non-Sel Kecil31 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara27 studi
- Kanker Kolorektal22 studi
- Kanker Paru21 studi
- Melanoma21 studi
- Mieloma Multipel21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Obesitas18 studi
- Leukemia Mieloid Akut17 studi
- Gagal Jantung17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.